IHAM
Integral Health Asset Management Portfolio holdings
AUM
$1.07B
1-Year Est. Return
40.53%
1 Year Est. Return
+40.53%
AUM
$903M
AUM Growth
-$228M
(-20%)
Holding
109
Top Buys
| 1 | +$28.3M | |
| 2 | +$27.9M | |
| 3 | +$22.6M | |
| 4 |
Baxter International
BAX
|
+$17.1M |
| 5 |
Ascendis Pharma
ASND
|
+$15.6M |
Top Sells
| 1 | +$30.3M | |
| 2 | +$29.6M | |
| 3 | +$29.3M | |
| 4 |
Intuitive Surgical
ISRG
|
+$20.9M |
| 5 |
CVS Health
CVS
|
+$20.3M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Insmed
INSM
$33.7B
| $118M | 12.58% |
1,550,000
|
|
||
2
Boston Scientific
BSX
$150B
| $65.6M | 6.98% |
650,000
+100,000
|
|
||
3
Cytokinetics
CYTK
$6.92B
| $44.2M | 4.7% |
1,100,000
+100,000
|
|
||
4
Tenet Healthcare
THC
$18.6B
| $37M | 3.94% |
275,000
-125,000
|
|
||
5
Mineralys Therapeutics
MLYS
$3.1B
| $36.5M | 3.89% |
2,300,000
+1,425,000
|
|
||
6
Elevance Health
ELV
$76.1B
| $28.3M | 3.01% |
+65,000
|
|
||
7
Novartis
NVS
$252B
| $27.9M | 2.97% |
+250,000
|
|
||
8
Vera Therapeutics
VERA
$1.86B
| $27.6M | 2.94% |
1,150,000
|
|
||
9
Encompass Health
EHC
$12.7B
| $27.3M | 2.91% |
270,000
-30,000
|
|
||
10
Medtronic
MDT
$120B
| $27M | 2.87% |
300,000
+150,000
|
|
||
11
Gilead Sciences
GILD
$150B
| $19.6M | 2.09% |
175,000
-25,000
|
|
||
|
12
Baxter International
BAX
$11.8B
| $17.1M | 1.82% |
+500,000
|
|
||
13
Fresenius Medical Care
FMS
$16B
| $16.9M | 1.8% |
680,000
+80,000
|
|
||
14
Neurocrine Biosciences
NBIX
$14.3B
| $16.6M | 1.77% |
150,000
-10,000
|
|
||
|
15
Ascendis Pharma
ASND
$12.2B
| $15.6M | 1.66% |
+100,000
|
|
||
16
Edgewise Therapeutics
EWTX
$1.6B
| $14.8M | 1.58% |
675,000
+125,000
|
|
||
17
BrightSpring Health Services
BTSG
$6.03B
| $14M | 1.49% |
775,000
-175,000
|
|
||
|
18
CVS Health
CVS
$104B
| $13.6M | 1.44% |
200,000
-300,000
|
|
||
19
Alnylam Pharmaceuticals
ALNY
$60.7B
| $13.5M | 1.44% |
50,000
+5,000
|
|
||
20
uniQure
QURE
$3.76B
| $13.3M | 1.41% |
1,250,000
+150,000
|
|
||
|
BPMC
21
DELISTED
Blueprint Medicines
BPMC
| $12.8M | 1.37% |
145,000
-130,000
|
|
||
22
AbbVie
ABBV
$403B
| $12.6M | 1.34% |
+60,000
|
|
||
23
RadNet
RDNT
$6.43B
| $12.4M | 1.32% |
+250,000
|
|
||
24
GE HealthCare
GEHC
$35.7B
| $12.1M | 1.29% |
+150,000
|
|
||
25
Krystal Biotech
KRYS
$5.39B
| $10.8M | 1.15% |
60,000
+5,000
|
|